Blog
10-Channel Medical Charger PCBA Case Study
Medical PCBA project often gets stuck in 3 options: cost discipline, BOM stability for FDA, and the freedom to iterate on human-factors findings rarely come from the same vendor. EMS shops built for cost protection margin by locking the BOM. Shops built for iteration charge for the engineering bandwidth that lost BOMs require. The FDA’s design control framework asks for both at once.
| Pressure | Source | What It Demands From The Supplier |
|---|---|---|
| Unit Cost | PE-backed margin targets | Transparent tier pricing, a clear cost ladder, and no hidden NRE charges |
| BOM Stability | FDA 21 CFR Part 820, DHF/DMR | Formal change control for every substitution, with ECO-grade documentation |
| HFE Iteration | IEC 62366-1 Clause 5.7 formative loop | Fast prototype turnaround and component-level traceability across revisions |
A US-based medical device CDMO, privately held and PE-backed, with more than 350 completed medical projects on the wall, is moving a 10-channel wearable biosensor charger toward FDA submission. They asked for a quote, then a meeting. They told us cost matters more than turn time. They also told us the BOM has to hold up under FDA scrutiny while their human-factors engineers keep finding things to change. Both at the same time.
Project Background
Client’s Engineering Team
The client runs a 12,000 sq ft ISO 13485 facility staffed by a principal engineering team averaging more than 20 years of experience. They design medical devices end-to-end and integrate them. They do not fabricate boards. PCBA assembly is outsourced by design, a deliberate split that keeps their three principal electrical engineers focused on system architecture rather than supplier management.
Functionally, the board powers up to ten wearable biosensors at once, with each channel switched independently by its own PMIC.
Board Specifications
| Parameter | Spec |
|---|---|
| Part Number | 01126-01015 Rev 0.1 |
| Dimensions | 190.75 × 112.52 mm (7.51 × 4.43 in) |
| Thickness | 1.57 mm (0.062 in) |
| Layer Count | 2 |
| Substrate | FR4 Tg180 |
| Surface Finish | ENIG, per IPC-4552 |
| Copper Weight | 1 oz inner and outer, 35 µm |
| Solder Mask / Silkscreen | Green / white, top side only |
| Panelization | Single-out, no array |
| BOM Lines | 24 |
| Component Count | Approximately 125 |
| Architecture | 10-channel power distribution |
| Quantity Ladder | 100 / 1,000 / 2,000 |
Why This Build Was Difficult
PE ownership pushes unit cost down. The board is a power management subsystem, useful but not differentiating, so it sits squarely in the cost-sensitive category.
FDA 21 CFR Part 820 requires every BOM substitution after design freeze to go through formal change control, traceable to the device history file and device master record. The client said it directly: “stable BOM to meet FDA compliance for medical products.” A supplier that handles substitutions casually is disqualified before the first build.
And IEC 62366-1 Clause 5.7 formative usability evaluations keep surfacing issues — connector alignment, indicator visibility, casing temperature — that loop back to the PCBA. Two to five revision cycles between EVT and DVT lock is realistic for this product class. A supplier that cannot turn protos quickly, hold component-level traceability across revisions, and feed clean ECO documentation back into the client’s DHF will quietly break the FDA timeline.
The villain is not a single weak link. It is the gap between mass-EMS economics and medical standards, which by regulation requires both repetition and disciplined change. Most suppliers pick a side. This program needs both.
Twelve Thousand Kilometres for a Handshake
We flew from Shenzhen to Colorado before quoting a single tooling fee. Two days of travel — across the Pacific, through Denver, and south to the client’s facility.
Scott met us at the door and walked us straight to the bench where the biosensor charging cradle sat. He explained how the ten-channel architecture had evolved after their latest usability study, and why the Rev 0.1 BOM was already provisional. That single conversation surfaced more engineering context than three months of email could have.
We had a meeting. The discussion stayed practical: cost structure, BOM change-control workflow, which components they wanted us to procure and which specialty parts they would ship from their own stock. We walked through our Shenzhen, Malaysia, and Mexico production options; they walked us through their DHF templates and explained exactly how change records needed to flow back for FDA compliance.
Two engineering teams working through the same BOM with a whiteboard between them. By the end of the day the scope was agreed: turnkey PCBA with full procurement, flying-probe and electrical testing on our side, so their three principal engineers could stay on system design instead of chasing suppliers.
It was a good meeting. Both sides left with the same checklist.
Where the Engineering Risks Actually Live
Warpage on a board that’s almost too thin
A two-layer build without an inner copper plane has nothing to constrain the layers if their copper coverage is uneven. The PCBCool DFM protocol holds top-to-bottom copper coverage within ±15 % and tunes the lamination cycle for the Tg180 resin system, which is harder to drill than standard FR4 and chews through bits roughly 15–20 % faster.
A ten-channel architecture hiding in plain sight
The board structure is visible from the BOM. One PMIC, one output, one enable line, replicated ten times. That topology pushes layout review beyond standard SI checks: thermal isolation between adjacent PMICs and ground coupling through shared returns both have to be verified before the first build.
A capacitor swap that would have failed
The original Rev 0.1 BOM substituted Murata NFM21PC104 for thirteen X2Y feedthrough capacitors at C1, C2, and C14–C41. NFM21PC104 is a feedthrough capacitor. It is not an X2Y type. The two are not interchangeable; their balanced-capacitance behaviour and EMI characteristics differ enough that swapping one for the other quietly breaks the filtering the part exists to provide. A pre-production BOM review caught the substitution and proposed Yageo CX0805MRX7R7BB104 as the correct X2Y equivalent.
Worth asking whether your current supplier would have caught that before first article, or after.
Why FR4 Tg180
The board carries multi-ampere load through a TPSM843620SITR rated to 6 A at 4–18 V input, so the substrate sees real thermal cycling in service. The CTE difference is not academic. It is the gap between via barrels that survive the device’s service life and via barrels that crack in the field.
| Parameter | FR4 Tg180 | Standard FR4 (Tg130–140) |
|---|---|---|
| Glass Transition Tg | 170–180 °C | 130–140 °C |
| Z-Axis CTE, Above Tg | 140–165 ppm/°C | 250–300 ppm/°C |
| Total Z-Axis Expansion, 50–260 °C | 2.0–2.5% | 3.5–4.5% |
| Td, Decomposition Temperature | 340–350 °C | 300–320 °C |
| T288 Endurance | 10–15 min | 3–5 min |
| Material Cost Premium | +25 to +40% | Baseline |
| Drill Bit Consumption | +15 to +20% | Baseline |
Material cost runs 25–40 % over standard FR4, paid back across the warranty period rather than the BOM line.
ENIG without the black pad
Black pad is the failure mode that destroys medical-device fielded-life claims. The IPC spec exists because suppliers who don’t control phosphorus to the right window produce boards that solder fine on the line and fail in service.
Supply chain risks
| Severity | Component | Issue | Mitigation |
|---|---|---|---|
| High | RT9728BHGE × 10 (U2–U11) | 7-week Richtek lead time creates an approximately 2-month batch cycle at volume | Pre-position buffer stock against project restart; qualify alternate PMIC in parallel |
| High | TPSM843620SITR (U1) | TI manufacturer price control and tariff exposure | Lock long-range procurement before the 1,000-unit ramp |
| Medium | J1 power jack PJ-036AH-SMT-TR | Alternate part DAILYLON DC0088D-AH is under client review | Provide verification samples for J1 before any batch commitment |
| Low | Samsung CL21A226, discontinued | Source EOL risk | Murata GRM21BR61E226ME44L confirmed in alternate log |
The Standards That Frame the Build
| Standard | Scope | Key Requirement On This Board |
|---|---|---|
| IEC 60601-1 | Dielectric isolation and patient safety | 2×MOPP at 250 V AC: creepage ≥ 8 mm, clearance ≥ 5 mm; 4,000 V AC withstand for 1 minute; solder mask is not credited toward creepage |
| IEC 62366-1 | HFE iteration loop | Clause 5.7 formative evaluations are a regulatory requirement, not a project preference, so change orders should be expected |
| IPC-4552 | ENIG plating control | Ni 3–5 µm, Au 0.05–0.15 µm, P 8–12 wt% |
| FDA 21 CFR 820.30(i) | Design change control | Every change must be evaluated against validation status and remain traceable to DHF/DMR |
Quality Control Assurance
Advanced Factory Facilities
PCBCool holds ISO 9001, ISO 14001, ISO 13485, UL, RoHS, and REACH certifications across two Shenzhen facilities founded in 2008, with additional capacity in Malaysia and Mexico for nearshoring or trade-compliance purposes. In any plant, we apply the consent and strick QC SOP.
Our Inspection matrix
| Stage | Method | Spec / Target |
|---|---|---|
| IQC | Tg verification by DSC | Tg180 confirmed per laminate lot |
| IQC | ENIG plating thickness by XRF | Ni 3–5 µm / Au 0.05–0.15 µm |
| IQC | Component traceability log | MPN + manufacturer lot + date code per part |
| IQC | Approved alternate registration | Yageo, Murata, and DAILYLON approved before production entry |
| IPQC | Reflow profile recording | Recorded per batch against the Tg180 thermal budget |
| IPQC | X2Y placement symmetry | 100% post-reflow inspection; asymmetric mounting compromises the EMI filtering this part is intended to provide |
| IPQC | Large-format warpage | Measured and documented per lot |
| OQC | AOI | 100% solder joint coverage and polarity inspection |
| OQC | X-ray | Inspection of all obscured or hidden solder joints |
| OQC | Flying Probe | Full electrical net test; no fixture investment at EVT, with a clean ICT path at 1,000+ units |
ECO handling is the part that makes or breaks medical supplier relationships. FDA 21 CFR 820.30(i) requires every design change to be evaluated against validation status. Every BOM revision generates a documented change record cross-referenced to the client’s DHF and DMR entries, with traceability logs updated in step. Connector swaps, indicator changes, thermal layout adjustments — handled as routine change events, not exceptions. The full workflow is available for the client’s audit team ahead of formal qualification, on request.
From Sample to 2,000 Units
| Phase | Trigger | Volume | Output |
|---|---|---|---|
| 0 — Pre-Restart Alignment | T-7 days before project restart | — | Rev 02 BOM confirmation; tooling fees and tier pricing locked |
| 1 — Sample Build | Project restart | 1–2 sets | Full IQC → IPQC → OQC + Flying Probe; shipment after technical pass |
| 2 — EVT Batch | Sample acceptance | 25 units | First article inspection report, process validation package, and DHF-compatible traceability |
| 3 — Production Ramp | EVT acceptance | 100 → 1,000 → 2,000 | RT9728BHGE buffer activates at 100 units; sustained ramp |
Cost ladder
| Quantity Step | Unit Cost Reduction | Primary Driver |
|---|---|---|
| 25 → 100 | −50 to −60% | NRE amortization, first-article fee spread, and MOQ effects |
| 100 → 1,000 | −50 to −60% | Volume material discounts, stencil amortization, and line efficiency |
| 1,000 → 2,000 | −20 to −30% | Approaching the cost floor for two-layer construction |
Final Thoughts
The program cleared sample acceptance and EVT without issues. Production has since ramped through the 1000-unit milestone and is running sustained batches toward the high volume. The RT9728BHGE buffer stock that was pre-positioned during Phase 0 has already absorbed two Richtek lead-time slips without interrupting the build schedule. BOM revision control — the concern the client raised in our very first conversation — has held through three ECOs, each documented, cross-referenced to the DHF, and closed within the agreed review window.
Frequently Asked Questions (FAQ)
A: Not always. It depends on the manufacturer, the specific project, and customer requirements. For projects with higher reliability demands, such as medical and automotive electronics, AOI is typically performed on every board.
A: Yes. For projects with special quality requirements, PCBCool can follow customer-defined inspection priorities, acceptance criteria, tolerance ranges, or specific defect control requirements.
Andy is an experienced PCB industry professional with decades of experience in PCB manufacturing, assembly, and customer support. At PCBCool, he leads the marketing team and helps turn practical project experience into useful technical content for engineers, buyers, and product developers.
